Medical writing support, under the direction of the authors, was provided by Eric Comeau, Ph.D., of CMC Connect, McCann Health Medical Communications and was funded by Pfizer Inc., New York, NY, USA, in accordance with Good Publication Practice (GPP3) guidelines (Ann Intern Med 2015;163:461464).
Framing BPC-157 realistically positions it as a recovery-support peptide rather than a primary anabolic agent for skeletal muscle growth BPC-157
Drug repurposing: misconceptions, challenges, and opportunities for academic researchers
At Moonshot Medical, we track body composition via DEXA to ensure you're losing fat, not muscle
October, 1998.
The Current Challenges in Regenerative Medicine It Addresses Modern medicine faces significant challenges in managing conditions characterized by chronic, low-grade inflammation and a diminished capacity for tissue repairhallmarks of the aging process